Skip to main content
Abliva logo

Abliva — Investor Relations & Filings

Ticker · ABLI ISIN · SE0002575340 LEI · 5493005YV22OTMUHZ183 ST Manufacturing
Open in API
Filings indexed 594 across all filing types
Latest filing 2021-08-19 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ABLI

About Abliva

https://abliva.com

Abliva is a biopharmaceutical company that discovers and develops medicines for the treatment of primary mitochondrial diseases. These are rare, congenital, and often severe genetic disorders that occur when the cell's energy converters, the mitochondria, are dysfunctional. The company's research and development is focused on creating novel therapies aimed at restoring mitochondrial function and addressing the significant unmet medical needs of patients. Abliva's primary goal is to deliver treatments that provide meaningful clinical benefits for individuals suffering from these debilitating conditions.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report January – June 2021' and contains detailed financial data, including net revenues, loss before tax, and loss per share for the second quarter and the first half of the year. It also includes management commentary, operational updates, and clinical trial progress. As it covers a period shorter than a full fiscal year and contains substantive financial statements and analysis, it is classified as an Interim/Quarterly Report. H1 2021
2021-08-19 English
Amended number of shares and votes in Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly announces an 'Amended number of shares and votes' resulting from a 'directed new issue of shares' approved by the Board and EGM. This directly relates to a change in the company's capital structure and share count. The document is short (2421 chars) and appears to be a press release announcing this specific corporate action. The most fitting category is 'Share Issue/Capital Change' (SHA), as it details the resulting total number of shares after a new issue. While it could potentially be a general Regulatory Filing (RNS), SHA is more specific to the content described.
2021-05-31 English
Ändring av antal aktier och röster i Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short announcement in Swedish titled "Ändring av antal aktier och röster i Abliva AB (publ)" (Change in the number of shares and votes in Abliva AB (publ)). It explicitly states that the number of shares and votes has increased due to a directed new share issue approved by the board and EGM. This directly relates to a change in the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA). Although it is a regulatory announcement, the specific nature of the content (change in total shares following an issuance) makes SHA a more precise classification than the general 'RNS'. The document length is short (2103 chars) and it announces a corporate action rather than being the full report of that action, but SHA covers the substance of the announcement itself.
2021-05-31 Swedish
Beslut vid årsstämma i Abliva AB (publ)
AGM Information Classification · 1% confidence The document is titled "Beslut vid årsstämma i Abliva AB (publ)" which translates to "Resolutions at the Annual General Meeting of Abliva AB (publ)". The content details decisions made regarding the approval of financial statements, dividend policy (no dividend), board member remuneration, election of the board and auditor, and authorizations for future share issues and employee option programs. These are all standard items addressed and resolved during an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information). The document is a summary of the resolutions, not just an announcement of a report, making AGM-R more specific than RPA or RNS.
2021-05-20 Swedish
Resolutions from Annual General Meeting in Abliva AB (publ)
AGM Information Classification · 1% confidence The document explicitly states it contains the "Resolutions from Annual General Meeting in Abliva AB (publ)" and details decisions made during the AGM regarding dividends, board elections, fees, and authorizations (like share issues and stock options). This content directly relates to the formal proceedings and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information). The document is not a general regulatory filing (RNS) or a proxy solicitation (PSI), but the specific results of the meeting itself.
2021-05-20 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport januari – mars 2021' (Interim Report January – March 2021) and contains comprehensive financial data, including income statements, business highlights, and management commentary for the first quarter. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-20 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.